Osteonic Co

Osteonic Co EBITDA per Share

The EBITDA per Share of Osteonic Co (226400.KQ) as of Nov 2, 2026 is 684.59 KRW. In the previous year, EBITDA per Share was 580.42 KRW — a change of 17.95% (higher).

EBITDA per Share

684.59KRW

YoY

17.95%

Last updated:

EBITDA per Share of Osteonic Co is 2025 684.59 KRW. EBITDA per Share of Osteonic Co was 2024 580.42 KRW. It decreases by 17.95% higher compared to the previous year.

The Osteonic Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-252.38 KRW
Jan 1, 2019
19.57 KRW
Jan 1, 2020
48.74 KRW
Jan 1, 2021
76.68 KRW
Jan 1, 2022
238.70 KRW
Jan 1, 2023
374.51 KRW
Jan 1, 2024
580.42 KRW
Jan 1, 2025
684.59 KRW
The Osteonic Co EBITDA per Share history
YEAREBITDA per ShareYoY
684.59KRW+17.95%
580.42KRW+54.98%
374.51KRW+56.90%
238.70KRW+211.28%
76.68KRW+57.34%
48.74KRW+149.00%
19.57KRW-107.76%
-252.38KRW-265.27%
152.70KRW+51.87%
100.55KRW+308.58%
24.61KRW-78.97%
117.00KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Osteonic Co Stock analysis

What does Osteonic Co do? Osteonic Co Ltd develops and manufactures medical equipment, primarily focusing on cranio maxilla facial (CMF) systems and trauma systems. These products, including plates and screws, are used for fixing and healing broken bones in the cranium, face, jaw, hands, and feet. The company distributes its medical equipment domestically within Seoul and internationally to overseas markets. The firm's products are designed for medical professionals and healthcare facilities requiring orthopedic solutions. Osteonic Co Ltd targets hospitals and clinics that need reliable surgical tools for bone fixation and implant procedures. The company's domestic and international distribution channels support its market reach in both local and global healthcare sectors. Osteonic Co Ltd's revenue streams come from the sale of CMF systems, trauma systems, and related medical equipment. The products are sold to hospitals, clinics, and medical distributors across domestic and overseas markets. The company's focus on specialized orthopedic solutions positions it within the medical equipment manufacturing industry. Osteonic Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Osteonic Co stock

EBITDA per Share of Osteonic Co is 684.59 KRW in 2025.

EBITDA per Share of Osteonic Co changed from 580.42 KRW to 684.59 KRW, representing a 17.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Osteonic Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Osteonic Co

All Key Metrics — Osteonic Co